Policy / Pricing UK partners with Eli Lilly on obesity plan PharmaphorumThe UK has teamed up with Eli Lilly on initiatives, backed with 85 million in funding, to expand access to treatment for obesity.Metabolic & GLP-1Read full story pharminent June 29, 2026 (Last updated: June 29, 2026) Pharmaphorum The UK has teamed up with Eli Lilly on initiatives, backed with 85 million in funding, to expand access to treatment for obesity. Metabolic & GLP-1 Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Zymeworks cuts deal to buy Theravance for $929m in cashNext: Viridian’s Lumvoa Wins FDA Approval, Taking Direct Aim at Amgen’s Tepezza in Thyroid Eye Disease Related Stories Policy / Pricing Germany approves healthcare costs overhaul despite significant pharma opposition pharminent July 13, 2026 Policy / Pricing Decoding Medicare Advantage Coding Intensity pharminent July 1, 2026 Policy / Pricing EFPIA report adds to pressures on EU drug pricing policy pharminent June 24, 2026
